Evidence map›Paper›PMID 24120973›Full record

ArticleAmerican journal of obstetrics and gynecology2014

Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers.

Hendrée E Jones, Krisanna Deppen, Mark L Hudak, Lisa Leffert, Carol McClelland, Leyla Sahin, Jacquelyn Starer, Mishka Terplan, John M Thorp, James Walsh and 1 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03098407 (A Pilot Randomized Comparative Effectiveness Clinical Trial of Buprenorphine vs. Methadone for the Treatment of Opioid Dependence in Pregnancy.), which is not on this map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03098407 nacompletednot on this mapstarted 2017, after this paper: background citation

A Pilot Randomized Comparative Effectiveness Clinical Trial of Buprenorphine vs. Methadone for the Treatment of Opioid Dependence in Pregnancy.

TypeinterventionalSponsorUniversity of PittsburghRan2017 to 2020Enrolled55ConditionsOpioid-Related Disorders, PregnancyArmsBuprenorphine, Methadone
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Guideline
  2. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2016
    Trial
  3. Article
  4. Hospital Care for Pregnant Persons With OUD Review.American journal of medicine open · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Physician Referrals During Prenatal Care.Maternal and child health journal · 2021
    Article
  14. Review
  15. Scoping Review of the Associations Between Perinatal Substance Use and Perinatal Depression and Anxiety.Journal of obstetric, gynecologic, and neonatal nursing : JOGNN · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Hendrée E JonesUNC Horizons Program, Department of Obstetrics and Gynecology, UNC School of Medicine, University of North Carolina at Chapel Hill, Carrboro, NC. Electronic address: hendree_jones@med.unc.edu.
Krisanna DeppenDepartment of Family Medicine, Grant Medical Center, Columbus, OH.
Mark L HudakDepartment of Pediatrics, University of Florida College of Medicine-Jacksonville, FL.
Lisa LeffertDepartment of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital, Boston, MA.
Carol McClellandUNC Horizons Program, Department of Obstetrics and Gynecology, UNC School of Medicine, University of North Carolina at Chapel Hill, Carrboro, NC.
Leyla SahinPediatric and Maternal Health Staff, Maternal Health Team, Office of New Drugs, Food and Drug Administration, Silver Spring, MD.
Jacquelyn StarerAddiction Recovery Program, Brigham and Women's Faulkner Hospital, Boston, MA.
Mishka TerplanDepartment of Obstetrics, Gynecology & Reproductive Sciences, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD.
John M ThorpUNC Horizons Program, Department of Obstetrics and Gynecology, UNC School of Medicine, University of North Carolina at Chapel Hill, Carrboro, NC.
James WalshAddiction Recovery Service, Swedish Medical Center, Seattle, WA.
Andreea A CreangaDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
University of North Carolina at Chapel Hill · USBrigham and Women's Faulkner Hospital · USCenters for Disease Control and Prevention · USGrant Medical Center · USMassachusetts General Hospital · USSwedish Medical Center · USUniversity of Florida · USUniversity of Maryland, Baltimore · US

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Intramural CDC HHS CC999999NICHD NIH HHS P2C HD050924
6 · The paper itself

Abstract

We review clinical care issues that are related to illicit and therapeutic opioid use among pregnant women and women in the postpartum period and outline the major responsibilities of obstetrics providers who care for these patients during the antepartum, intrapartum, and postpartum periods. Selected patient treatment issues are highlighted, and case examples are provided. Securing a strong rapport and trust with these patients is crucial for success in delivering high-quality obstetric care and in coordinating services with other specialists as needed. Obstetrics providers have an ethical obligation to screen, assess, and provide brief interventions and referral to specialized treatment for patients with drug use disorders. Opioid-dependent pregnant women often can be treated effectively with methadone or buprenorphine. These medications are classified as pregnancy category C medications by the Food and Drug Administration, and their use in the treatment of opioid-dependent pregnant patients should not be considered "off-label." Except in rare special circumstances, medication-assisted withdrawal during pregnancy should be discouraged because of a high relapse rate. Acute pain management in this population deserves special consideration because patients who use opioids can be hypersensitive to pain and because the use of mixed opioid-agonist/antagonists can precipitate opioid withdrawal. In the absence of other indications, pregnant women who use opioids do not require more intense medical care than other pregnant patients to ensure adequate treatment and the best possible outcomes. Together with specialists in pain and addiction medicine, obstetricians can coordinate comprehensive care for pregnant women who use opioids and women who use opioids in the postpartum period.

Indexed as

Physician-Patient RelationsAnalgesics, OpioidBuprenorphineConfidentialityDose-Response Relationship, DrugEmergency Service, HospitalFemaleHumansLabor, ObstetricLabor PainMental DisordersMethadoneNarcotic AntagonistsOpiate Substitution TreatmentOpioid-Related DisordersPostnatal CareAnalgesics, OpioidBuprenorphineMethadoneNarcotic Antagonistsopioid-agonistopioid usesubstance use

Identifiers

PMID24120973
PMCPMC7213596
OpenAlexW2008582453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.